Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (661-670 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|October 25, 2022
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flaresFrancesco Carubbi, Alessia Alunno, Jessica Santilli, et al.
RMD Open|September 14, 2022
Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseasesJoshua Zarbl, Ekaterina Eimer, Camilla Gigg, et al.
RMD Open|September 15, 2022
Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registryCasper Webers, Astrid van Tubergen, Harald E Vonkeman, et al.
RMD Open|September 15, 2022
Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE StudyYuichi Saito, Atsushi Tanaka, Yuji Koide, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
RMD Open|September 27, 2022
Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosisSongxin Yan, Yu Peng, Ziyan Wu, et al.
RMD Open|September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritisLaura C Coates, Josef S Smolen, Philip J Mease, et al.
RMD Open|September 19, 2022
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosusPhilippe Mertz, Matteo Piga, Elisabetta Chessa, et al.
RMD Open|November 29, 2023
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational studyAlexandra Ladouceur, Thomas Barnetche, Gael Mouterde, et al.
RMD Open|November 29, 2023
Excess mortality following a first and subsequent osteoporotic fracture: a Danish nationwide register-based cohort study on the mediating effects of comorbiditiesEmilie Rosenfeldt Christensen, Anne Clausen, Tanja Gram Petersen, et al.
Pageof 192

Showing results (661-670 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|October 25, 2022
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flaresFrancesco Carubbi, Alessia Alunno, Jessica Santilli, et al.
RMD Open|September 14, 2022
Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseasesJoshua Zarbl, Ekaterina Eimer, Camilla Gigg, et al.
RMD Open|September 15, 2022
Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registryCasper Webers, Astrid van Tubergen, Harald E Vonkeman, et al.
RMD Open|September 15, 2022
Impact of febuxostat on visit-to-visit blood pressure variability: insights from the randomised PRIZE StudyYuichi Saito, Atsushi Tanaka, Yuji Koide, et al.
RMD Open|September 16, 2022
Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohortMarie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, et al.
RMD Open|September 27, 2022
Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosisSongxin Yan, Yu Peng, Ziyan Wu, et al.
RMD Open|September 28, 2022
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritisLaura C Coates, Josef S Smolen, Philip J Mease, et al.
RMD Open|September 19, 2022
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosusPhilippe Mertz, Matteo Piga, Elisabetta Chessa, et al.
RMD Open|November 29, 2023
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational studyAlexandra Ladouceur, Thomas Barnetche, Gael Mouterde, et al.
RMD Open|November 29, 2023
Excess mortality following a first and subsequent osteoporotic fracture: a Danish nationwide register-based cohort study on the mediating effects of comorbiditiesEmilie Rosenfeldt Christensen, Anne Clausen, Tanja Gram Petersen, et al.
Pageof 192